Reply to: "The Impact of Donor Liver Fibrosis on Early Allograft Dysfunction and Ischemia-Reperfusion Injury."

We thank Bekki et al. for their insightful comments on our published paper in Hepatology, in which we demonstrated the impact of donor occult fibrosis on liver transplant (LT) outcomes including ischemia reperfusion injury (IRI) and early allograft dysfunction (EAD).